IronBridge Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

IronBridge Private Wealth’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-176	Closed	-$11K	–	65
2021 Q4	$11K	Hold	176	–	–	0.01%	168
2021 Q3	$10K	Hold	176	–	–	0.01%	147
2021 Q2	$12K	Hold	176	–	–	0.01%	138
2021 Q1	$11K	Hold	176	–	–	0.01%	147
2020 Q4	$11K	Buy	+176	New	+$10.8K	0.01%	137

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

IronBridge Private Wealth's BMY Position: Q1 2022 in Review

IronBridge Private Wealth sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 176 shares — an estimated $11K sold.

IronBridge Private Wealth first reported a position in BMY in Q4 2020 and held it in 5 quarters. The position peaked at $12K in Q2 2021. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

IronBridge Private Wealth reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
IronBridge Private Wealth sold 176 Bristol-Myers Squibb shares in Q1 2022, an estimated $11K.
IronBridge Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 5 quarters.
IronBridge Private Wealth's Bristol-Myers Squibb position peaked at $12K in Q2 2021.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on IronBridge Private Wealth's 13F filing for Q1 2022, filed 16 May 2022.